Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yuichiro Miyoshi"'
Autor:
Masako Yamamoto, MD, Yuriko Kawase, MD, PhD, Hirohisa Kishi, MD, PhD, Yuichiro Miyoshi, MD, PhD, Hiroshi Mitsui, MD, PhD, Shigeki Sekine, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 25, Iss , Pp 39-42 (2022)
Externí odkaz:
https://doaj.org/article/feb0003f25c048d798079e24b8b46e58
Autor:
Tomohiro Shidahara, Shozo Ohsumi, Yuichiro Miyoshi, Mina Takahashi, Seiki Takashima, Kenjiro Aogi, Norihiro Teramoto
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Chemotherapy is often difficult to treat human epidermal growth factor receptor 2 (HER2)-positive metastatic recurrent breast cancer in the elderly, and no standard treatment has been established at this point. We experienced a case in which trastuzu
Externí odkaz:
https://doaj.org/article/674188a6bce94315b11aa61fbcff3e77
Autor:
Megumi Takaoka, Shozo Ohsumi, Yuichiro Miyoshi, Mina Takahashi, Seiki Takashima, Kenjiro Aogi, Teruhiko Shimizu, Norihiro Teramoto, Yasuko Yamamoto, Miki Okamura
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-5 (2021)
Abstract Background Hereditary breast and ovarian cancer (HBOC) syndrome is a susceptibility syndrome for cancers, such as breast and ovarian cancer, and BRCA1/2 are its causative genes. Annual breast-enhanced magnetic resonance imaging (MRI) is reco
Externí odkaz:
https://doaj.org/article/40509a5bfa7a41ffac779ea0f30a4b4f
Autor:
Takayuki Iwamoto, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, Yutaka Ogasawara, Minami Hatono, Seiji Yoshitomi, Kyoko Hara, Asako Sasahara, Shozo Ohsumi, Masahiko Ikeda, Hiroyoshi Doihara,1., Yuri Mizota, Seiichiro Yamamoto, Naruto Tairal
Publikováno v:
Clinical Breast Cancer; Jan2024, Vol. 24 Issue 1, p27-35, 9p
Autor:
Takayuki Iwamoto, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, Yutaka Ogasawara, Minami Hatono, Seiji Yoshitomi, Kyoko Hara, Asako Sasahara, Shozo Ohsumi, Masahiko Ikeda, Hiroyoshi Doihara, Yuri Mizota, Seiichiro Yamamoto, Naruto Taira
Background It is unclear what interventions can sustain long-term higherphysical activity (PA) to improve breast cancer outcomes. Thus, this study aimed to evaluate the long-term effects of interventions on PA after breast cancer treatment. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e27a5c85a4b0ef2885e01d5ddc054df9
https://doi.org/10.21203/rs.3.rs-2299245/v1
https://doi.org/10.21203/rs.3.rs-2299245/v1
Autor:
Norihiro Teramoto, Shozo Ohsumi, Tomohiro Shidahara, Seiki Takashima, Kenjiro Aogi, Yuichiro Miyoshi, Mina Takahashi
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Case Reports in Oncology, Vol 14, Iss 3, Pp 1632-1637 (2021)
Chemotherapy is often difficult to treat human epidermal growth factor receptor 2 (HER2)-positive metastatic recurrent breast cancer in the elderly, and no standard treatment has been established at this point. We experienced a case in which trastuzu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820275a14e39e500aa50c931954e7856
http://europepmc.org/articles/PMC8647049
http://europepmc.org/articles/PMC8647049
Autor:
Miyuki Doi, Shozo Ohsumi, Sachie Shimizu, Seiki Takashima, Sachiko Kiyoto, Yuichiro Miyoshi, Mina Takahashi, Kenjiro Aogi
Publikováno v:
Cancer Research. 80:P5-14
Introduction Scalp cooling during chemotherapy infusion to mitigate hair loss for breast cancer patients is becoming popular in European and North American countries. But there is little prospective data regarding hair recovery after chemotherapy wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2d778b0ae92d362f700920e6e57b5c8
https://doi.org/10.1158/1538-7445.sabcs19-p5-14-21
https://doi.org/10.1158/1538-7445.sabcs19-p5-14-21
Autor:
Yuichiro Miyoshi, Yasuko Yamamoto, Sachiko Kiyoto, Shozo Ohsumi, Mina Takahashi, Keika Kaneko, Miki Okamura, Kenjiro Aogi, Maya Uno, Seiki Takashima, Yumi Matsuyama
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 29:21-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e563d4a8ce347d1d4418ca13e9e6d72
https://doi.org/10.3804/jjabcs.29.21
https://doi.org/10.3804/jjabcs.29.21
Autor:
Norihiro Teramoto, Miki Okamura, Seiki Takashima, Teruhiko Shimizu, Kenjiro Aogi, Shozo Ohsumi, Megumi Takaoka, Mina Takahashi, Yuichiro Miyoshi, Yasuko Yamamoto
Publikováno v:
Surgical Case Reports
Surgical Case Reports, Vol 7, Iss 1, Pp 1-5 (2021)
Surgical Case Reports, Vol 7, Iss 1, Pp 1-5 (2021)
Background Hereditary breast and ovarian cancer (HBOC) syndrome is a susceptibility syndrome for cancers, such as breast and ovarian cancer, and BRCA1/2 are its causative genes. Annual breast-enhanced magnetic resonance imaging (MRI) is recommended f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d93219f6dff1d6cd0471e91d51f3c92
http://europepmc.org/articles/PMC8531180
http://europepmc.org/articles/PMC8531180
Autor:
Hiroko Yamashita, Norikazu Masuda, Mitsuchika Hosoda, Hiroyoshi Doihara, Nobumoto Tomioka, Naoko Ishida, Yuichiro Miyoshi, Tomofumi Osako, Masato Takahashi, Hiroyuki Yasojima, Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Touko Inao, Yoshiya Horimoto, Yumi Wanifuchi‑Endo
Publikováno v:
Oncology Letters
The value of assessing tumor infiltrating lymphocytes (TILs) in estrogen receptor (ER) positive/human epidermal growth factor receptor type 2 (HER2) negative breast cancer has yet to be determined. In the present study, a total of 184 cases with earl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03ca34d7477027f0bae0e4c982007d2
https://pubmed.ncbi.nlm.nih.gov/30675282
https://pubmed.ncbi.nlm.nih.gov/30675282